Real-time enrollment status for this primary open - angle glaucoma (poag) clinical trial
Current Status
Recruiting
Checked: November 15, 2026 at 3:26 PM UTC
| NCT Number | NCT07913074 |
| Recruiting Status | Recruiting |
| Condition | Primary Open - Angle Glaucoma (POAG) |
| Phase | PHASE2 |
| Target Enrollment | 96 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Tavo Biotherapeutics |
| Last Updated on CT.gov | November 3, 2026 (1 week ago) |
As of November 15, 2026: Clinical trial NCT07913074 is currently recruiting participants. This phase2 study for primary open - angle glaucoma (poag) is actively seeking new participants at 3 locations across the United States. The study is sponsored by Tavo Biotherapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07913074 is actively recruiting participants as of November 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07913074 was last updated 1 week ago (November 3, 2026). HelloStudys verifies this status automatically.